60
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Priapism following acute overdose of perphenazine: a case report

ORCID Icon, &
Article: 2339074 | Received 30 Nov 2023, Accepted 31 Mar 2024, Published online: 09 May 2024

References

  • Eland IA, van der Lei J, Stricker BH, et al. Incidence of priapism in the general population. Urology. 2001;57(5):1–4. doi: 10.1016/S0090-4295(01)00941-4.
  • Baños JE, Bosch F, Farré, M. Drug-induced priapism. Its aetiology, incidence and treatment. Med Toxicol Adverse Drug Exp. 1989;4(1):46–58.
  • Rezaee ME, Gross MS. Are we overstating the risk of priapism with oral phosphodiesterase type 5 inhibitors? J Sex Med. 2020;17(8):1579–1582. doi: 10.1016/j.jsxm.2020.05.019.
  • Juurlink D. Antipsychotics. In: Nelson LS, Howland M, Lewin NA, Smith SW, Goldfrank LR, Hoffman RS, editors. Goldfrank’s toxicologic emergencies. New York (NY): McGraw Hill; 2019.
  • Bivalacqua TJ, Allen BK, Brock GB, et al. The diagnosis and management of recurrent ischemic priapism, priapism in sickle cell patients, and Non-Ischemic priapism: an AUA/SMSNA guideline. J Urol. 2022;208(1):43–52. doi: 10.1097/JU.0000000000002767.
  • Giuliano F, Rampin O. Neural control of erection. Physiol Behav. 2004;83(2):189–201. doi: 10.1016/j.physbeh.2004.08.014.
  • Andersson KE, Wagner G. Physiology of penile erection. Physiol Rev. 1995;75(1):191–236. doi: 10.1152/physrev.1995.75.1.191.
  • Chan J, Alldredge BK, Baskin LS. Perphenazine-induced priapism. DICP. 1990;24(3):246–249. doi: 10.1177/106002809002400306.
  • Tejera C, Ramose-Lorenzi J. Priapism in a patient receiving perphenazine. J Clin Psychopharmacol. 1992;12(6):448–449.
  • Geraci MJ, McCoy SL, Crum PM, et al. Antipsychotic-induced priapism in an HIV patient: a cytochrome P450-mediated drug interaction. Int J Emerg Med. 2010;3(2):81–84. doi: 10.1007/s12245-010-0175-y.